The idea that enterprise sales average 12-18 months is a misleading myth. Sales cycles follow a power law: if you're solving a C-level executive's number one priority, the deal closes in weeks. Anything else gets deprioritized and drags on for a year or more.

Care.com's CEO found that selling care benefits to enterprises takes longer than expected—often 18-24 months. This is because rising healthcare costs consume HR budgets, pushing care, considered a "one B benefit," to subsequent budget years and elongating the sales cycle.

For bootstrapped startups in industries with long sales cycles and sparse feedback, like healthcare, building speculatively is extremely risky. The safest path is to de-risk development completely by only investing engineering time into features or customizations that a customer has already committed to and paid for.

The reality of hospital value analysis committees means product adoption takes years. Entrepreneurs must build this lengthy timeline into financial models and fundraising to ensure survival, rather than projecting rapid uptake.

Landing a major client in the B2B health tech space requires extreme persistence. Sales cycles can last for years, and success often depends on the long-term effort of 'chipping away' at barriers and objections. Resilience is more critical than having the perfect initial pitch.

Gaining FDA approval is not the finish line. Many innovative devices fail because they lack a clear reimbursement strategy. Founders must build the economic case for payers and providers in concert with their clinical and regulatory strategy from day one.

As Eleven Labs shifted to enterprise, the long 6-12 month sales cycles caused skepticism among its fast-paced PLG teams. To maintain morale, leadership had to actively shield the teams from the lengthy process, asking for trust until the enterprise deals began to materialize and prove the strategy.

Don't assume your best long-term customers are the easiest to win. They may have lower initial win rates, smaller deal sizes, and longer sales cycles. This creates a conflict for sales leaders who must hit quarterly numbers, forcing a trade-off between short-term wins and long-term value.

Sales cycles are lengthening because decisions now involve large committees (7-8 people) where no single individual wants to take the risk of making a bad choice. Sellers must navigate this group dynamic by building consensus and multi-threading effectively.